Page last updated: 2024-09-04

glucagon and Deaf Mutism

glucagon has been researched along with Deaf Mutism in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (33.33)	18.2507
2000's	1 (33.33)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Aiba, S; Baba, Y; Hirayama, K; Iga, R; Inaba, Y; Ishibashi, R; Ito, C; Kanayama, T; Kasahara, K; Koshizaka, M; Kuroda, Y; Maezawa, Y; Ohtani, R; Okano, K; Watanabe, S; Yokote, K	1
Akai, H; Chiba, M; Hinokio, Y; Hirai, A; Hirai, M; Kasuga, S; Ohtomo, M; Satoh, Y; Suzuki, S; Toyota, T	1
Brändle, M; Lehmann, R; Maly, FE; Schmid, C; Spinas, GA	1

Trials

1 trial(s) available for glucagon and Deaf Mutism

Article	Year
The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation. Diabetologia, 1998, Volume: 41, Issue:5 Topics: Adult; C-Peptide; Coenzymes; Deafness; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; DNA, Mitochondrial; Family Health; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hearing; Humans; Lactic Acid; Male; Middle Aged; Mothers; Point Mutation; Time Factors; Treatment Outcome; Ubiquinone	1998

Article

Year

The effects of coenzyme Q10 treatment on maternally inherited diabetes mellitus and deafness, and mitochondrial DNA 3243 (A to G) mutation.

Diabetologia, 1998, Volume: 41, Issue:5

Topics: Adult; C-Peptide; Coenzymes; Deafness; Diabetes Complications; Diabetes Mellitus; Diabetic Nephropathies; Diabetic Neuropathies; Diabetic Retinopathy; DNA, Mitochondrial; Family Health; Female; Glucagon; Glucose Intolerance; Glucose Tolerance Test; Hearing; Humans; Lactic Acid; Male; Middle Aged; Mothers; Point Mutation; Time Factors; Treatment Outcome; Ubiquinone

1998

Other Studies

2 other study(ies) available for glucagon and Deaf Mutism

Article	Year
Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes. Journal of diabetes investigation, 2023, Volume: 14, Issue:12 Topics: Blood Glucose; Deafness; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucagon; Glycemic Control; Humans; Hypoglycemic Agents; Maternal Inheritance; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors	2023
Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation. Diabetes care, 2001, Volume: 24, Issue:7 Topics: Adult; Arginine; Blood Glucose; C-Peptide; Deafness; Diabetes Complications; Diabetes Mellitus; DNA, Mitochondrial; Female; Genomic Imprinting; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Nuclear Family; Pedigree; Point Mutation; Reference Values; RNA; RNA, Mitochondrial; RNA, Transfer, Leu; Time Factors	2001

Article

Year

Imeglimin-mediated glycemic control in maternally inherited deafness and diabetes.

Journal of diabetes investigation, 2023, Volume: 14, Issue:12

Topics: Blood Glucose; Deafness; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Female; Glucagon; Glycemic Control; Humans; Hypoglycemic Agents; Maternal Inheritance; Middle Aged; Sodium-Glucose Transporter 2 Inhibitors

2023

Diminished insulin secretory response to glucose but normal insulin and glucagon secretory responses to arginine in a family with maternally inherited diabetes and deafness caused by mitochondrial tRNA(LEU(UUR)) gene mutation.

Diabetes care, 2001, Volume: 24, Issue:7

Topics: Adult; Arginine; Blood Glucose; C-Peptide; Deafness; Diabetes Complications; Diabetes Mellitus; DNA, Mitochondrial; Female; Genomic Imprinting; Glucagon; Glucose Tolerance Test; Humans; Insulin; Insulin Secretion; Islets of Langerhans; Kinetics; Male; Nuclear Family; Pedigree; Point Mutation; Reference Values; RNA; RNA, Mitochondrial; RNA, Transfer, Leu; Time Factors

2001